view low-bandwidth site

Wave 80 chief executive to address microsystems commercialization conference in Chongqing, China

Talk will highlight evolving challenges and opportunities in global health.

San Francisco, California, October 14, 2009. Daniel J. Laser, Ph.D., Wave 80's Chief Executive Officer and President, will speak at the 3rd International Workshop on Innovation and Commercialization of Micro and Nano Technology (ICMAN 2009), the company announced today.

The ICMAN workshop is a forum for thought leaders in fields ranging from energy to telecommunications to medicine to gather and exchange ideas on successfully bringing innovative new micro- and nanotechnology-based products to market.

Dr. Laser's presentation will focus on practical applications of micro and nanotechnology in medical devices and diagnostics for neglected infectious diseases in the developing world. He will share insight gained over three years developing Wave 80's lead product, the EOSCAPETM system, which which leverages low-cost microtechnology to achieve gold-standard molecular diagnostics performance in a compact-form-factor system which can be operated across the full spectrum of environments where clinical laboratory testing is needed, from sophisticated high-throughput laboratories to small clinics in remote areas.

About Wave 80

Wave 80 Biosciences is a research-driven medical technologies company developing innovative molecular assay methods, novel techniques for leukocyte analysis and fractionation, and next-generation clinical laboratory testing systems. The centerpiece of Wave 80’s product pipeline is the EOSCAPE family of high-performance, compact-form-factor systems for measurement of high-clinical-value biomarkers in peripheral blood. Wave 80 is headquartered in San Francisco, California.